Bone Metastasis on the Survival of Gefitinib Effective Patients

Clinical trial NCT03157310 · COMPLETED

Trial details

NCT number: NCT03157310
Sponsor: Qilu Hospital of Shandong University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Overal Survival, Non-small Cell Lung Cancer

Start date: 2009-05-01
Primary completion: 2013-05-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.